← Latest briefing

Health

Studies link menopause timing and hormone therapy to lower Alzheimer's risk

Observational research finds hormone replacement therapy and later menopause onset correlate with reduced cognitive decline, though researchers stress evidence remains mixed.

The short version

  • Two new studies highlight correlations between menopause timing, hormone replacement therapy (HRT), and dementia risk in women.
  • A study of more than 180,000 U.K. women linked HRT to lower rates of Alzheimer's, especially among those who started between ages 46 and 56 or underwent surgical menopause.
  • A separate study found earlier menopause onset was associated with faster cognitive decline and increased brain tissue damage markers decades later.
  • Researchers caution that the findings demonstrate correlation rather than causation, noting that clinical trials are required before treatment recommendations change.

Key facts

  • A study in Alzheimer's & Dementia tracking over 180,000 postmenopausal U.K. women over 13 years found HRT was associated with a 10 percent lower risk of all dementias and a 16 percent lower risk of Alzheimer's specifically.[Scientific American]
  • Women who underwent surgical menopause saw a 26 percent drop in dementia risk while using HRT, and starting treatment between ages 46 and 56 showed greater risk reduction than initiating later.[Scientific American]
  • Research published in JAMA Network Open linked earlier menopause onset with accelerated cognitive decline later in life, earlier Alzheimer's diagnoses, and faster growth of white matter hyperintensity volume.[Scientific American]
  • Study co-senior author Anne-Marie Minihane noted that previous research showed mixed results, including past findings where combined hormone therapy increased dementia risk in women over 65.[Scientific American]

What remains uncertain

  • The underlying biological mechanisms connecting menopause and hormone types to dementia remain unconfirmed, and it is unclear whether HRT directly protects against Alzheimer's disease or merely correlates with lower risk.[Scientific American]
  • Researchers have not established why women with surgical menopause exhibited stronger associations or why prior HRT studies have yielded conflicting results.[Scientific American]

Sources